Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON29047
NL-OMON29047
Not yet recruiting
Not Applicable

PREVENTION OF THE PROGRESSION OF VERY EARLY SYMPTOMSINTO ANKYLOSING SPONDYLITIS:A PLACEBO CONTROLLED TRIAL WITH ETANERCEPT.

investigator drive study supported by Wyeth0 sites80 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsankylosing spondylitis, inflammatory back pain, morning stiffness, chronic (low) back pain, arthiritis, buttock pain, dactylitis, enthestitis, psoriasis, non-gonococcal urethritis or cercvicitis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
ankylosing spondylitis, inflammatory back pain, morning stiffness, chronic (low) back pain, arthiritis, buttock pain, dactylitis, enthestitis, psoriasis, non-gonococcal urethritis or cercvicitis
Sponsor
investigator drive study supported by Wyeth
Enrollment
80
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
investigator drive study supported by Wyeth

Eligibility Criteria

Inclusion Criteria

  • •Patients to be included must meet the following criteria:
  • •1\. Age between 18\-45 years, both male and female;

Exclusion Criteria

  • •Specific medical exclusion criteria:
  • •1\. Definite AS (modified New York criteria (9\));

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
PREVENTION OF THE PROGRESSION OF VERY EARLY SYMPTOMSINTO ANKYLOSING SPONDYLITIS: A PLACEBO CONTROLLED TRIAL WITH ETANERCEPT - PREVAS
EUCTR2009-015515-40-NLWyeth Pharmaceuticals B.V.80
Completed
Phase 2
Prevention of the progression of very early symptoms into ankylosing spondylitisankylosing spondylitisspondyloarthritis10023213
NL-OMON36697Vrije Universiteit Medisch Centrum80
Completed
Not Applicable
Prodromal symptoms and early intervention to prevent a relapse
ISRCTN17350364Mental Health Care Services Drenthe (Netherlands)147
Recruiting
Not Applicable
Pre-frail New efforts to prevent the progression of frail by intervention of agarooligosaccharides in the elderlyfrail
JPRN-UMIN000046285Matsumoo university30
Not yet recruiting
Not Applicable
utrition Intervention In Metabolic Syndrome In Young People With Mental Illness (NIMSMI)
ACTRN12617000461392Western Sydney Local Health District120